Table 2 Incidence of CRBSI in the vancomycin-lock and control groups
Vancomycin-lock group (n = 68) | Control group (n = 69) | RR (95%CI) | p value | |
|---|---|---|---|---|
CRBSI n (%) | 3 (4.4%) | 15 (21.7%) | 0.20 (0.06–0.67) | 0.004 |
Confirmed n (%) | 3 (4.4%) | 11 (15.9%) | 0.28 (0.08–0.95) | 0.045 |
Suspected n (%) | 0 | 4 (5.8%) | 0.11 (0.01–2.05) | 0.120 |